TUESDAY, Sept. 17, 2024 -- For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1...
Vous n'êtes pas connecté
MONDAY, Aug. 12, 2024 -- For patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonist) is associated with lower risks for all-cause mortality and...
TUESDAY, Sept. 17, 2024 -- For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1...
Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used in the treatment of medlinktype 2 diabetes/medlink and...
Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought,...
MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
TUESDAY, Sept. 17, 2024 -- Positive airway pressure (PAP) utilization is associated with lower all-cause mortality and major adverse cardiovascular...
A new study has shown that eating more fruits and vegetables can significantly lower blood pressure and improve heart and kidney health in people with...
While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related...
While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related...